MENU
XLO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Xilio Therapeutics (XLO) Ownership - Who owns Xilio Therapeutics?
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments... Show more
Profile
Industry
N/A
Address
828 Winter Street
Phone
+1 857 524-2466
Employees
73
Web
https://www.xiliotx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
38.91M
P/E Ratio
N/A
Total Cash
55.29M
Projected Growth
N/A
Total Debt
8.14M
Revenue
6.34M
Risk (Beta)
-0.24
Dividend Yield
N/A
Total Cash/Share
1.07
Total Debt/Equity
N/A
Revenue/Share
0.12 USD as % of share price
Fundamentals
XLO
Capitalization
38.9M
P/E Ratio
N/A
Risk (Beta)
-0.24
Dividend Yield
N/A
Total Cash
55.3M
Total Cash/Share
1.07
Total Debt
8.14M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.12%
Revenue
6.34M
ROE
N/A
Book Value
17.6M
P/B Ratio
2.21
Cash Flow
N/A
Earnings
-1.09
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
2.21
Current Revenue Per Employee
23616.44
Dividends Per Share - Security
N/A
EBITDA
-58M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-88.24
Shares Held By Institutions
18M
Shares Outstanding - Current
51.8M
Total Liabilities
53.5M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-25.445
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
828 Winter Street
Phone
+1 857 524-2466
Employees
73
Web
https://www.xiliotx.com